NICE rejects pancreatic cancer regimen over cost concerns - PMLiVE
Medical Tidbits, Allergan Confirms Generic Abraxane® Patent Challenge | MedCareer News
Abraxane (Albumin-bound Paclitaxel for Injectable Suspension): Uses, Dosage, Side Effects, Interactions, Warning
Generics | Drug Store News
ABRAXANE Loss of Exclusivity (LOE). When will the patents on ABRAXANE expire, and when will generic ABRAXANE be available?
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer - The New York Times
Cipla Remains Upbeat On Abraxane As US Generic Competition Looms :: Generics Bulletin
Abraxane for the Treatment of Late-Stage Pancreatic Cancer - Clinical Trials Arena
Glenmark, Particle Sciences to develop generic cancer drug - The Economic Times
Chemotherapy-Related Skin Toxicities - Cancer Therapy Advisor
US co Abraxis denied patent on cancer drug - Times of India
Glenmark takes aim at Celgene's Abraxane with complex generic deal | Fierce Pharma
Abraxane for the Treatment of Late-Stage Pancreatic Cancer - Clinical Trials Arena
CENTER FOR DRUG EVALUATION AND RESEARCH
New Generic will Cut into BMS's Top-Earning Cancer Drug | BioSpace
Abraxane Gains Indication for First-Line NSCLC Therapy - MPR
Abraxis Pharma Products 68817013450 - McKesson Medical-Surgical
NDC 68817-134 Abraxane Paclitaxel Injection, Powder, Lyophilized, For Suspension Intravenous
What's Next? Five Things To Look Out For In March :: Generics Bulletin
Abraxane - Uphar Speciality Pharma
Stephen V Liu, MD on Twitter: "Just learned that abraxane is on manufacturer backorder with no release date. Wondering if drug shortages are the downstream effect of supply chain issues and is
Abraxane Intravenous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Intaxel® Injection Vial | OKDERMO Skin Care
FDA panel questions Roche's Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now | Fierce Pharma
Glenmark, Particle Sciences ink deal to develop generic cancer drug Abraxane | Mint
